Overview of Dr. Vasan
Dr. Neil Vasan is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Yale School of Medicine and has been in practice 3 years. He is one of 118 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 377 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 20 publications and over 500 citings.
Office
161 Fort Washington Ave
New York, NY 10032Fax+1 212-305-0178
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 2013 - 2016
- Yale School of MedicineClass of 2013
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- NY State Medical License 2015 - 2025
- NJ State Medical License 2020 - 2021
- MA State Medical License 2013 - 2015
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- LIN28B-mediated PI3K/AKT pathway activation promotes metastasis in colorectal cancer models.Alice E Shin, Kensuke Sugiura, Secunda W Kariuki, David A Cohen, Samuel P Flashner
The Journal of Clinical Investigation. 2025-01-14 - 1 citationsMolecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations.Faiza Yasin, Ethan Sokol, Neil Vasan, Dean C Pavlick, Richard S P Huang
The Oncologist. 2024-12-06 - Single-Hit and Multi-hit PIK3CA Short Variant Genomic Alterations in Clinically Advanced Prostate Cancer: A Genomic Landscape Study.Michael F Basin, Carla M Miguel, Joseph M Jacob, Hanan Goldberg, Petros Grivas
Targeted Oncology. 2024-11-01
Press Mentions
- Navigating the Evolving Landscape of ER-Positive Metastatic Breast Cancer TreatmentJanuary 6th, 2025
- Year in Review Session Summarizes Important Breast Cancer Takeaways from 2024December 15th, 2024
- Special Session Explores Considerations Behind Breast Cancer Drug Approvals, TrialsDecember 15th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: